Page last updated: 2024-10-19

phenethylamine and Acute Confusional Senile Dementia

phenethylamine has been researched along with Acute Confusional Senile Dementia in 4 studies

phenethylamine: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7016
2-phenylethylamine : A phenylethylamine having the phenyl substituent at the 2-position.

Research Excerpts

ExcerptRelevanceReference
"Deprenyl/Selegiline (DEP), created by Joseph Knoll in the 1960s, registered in more than 60 countries to treat Parkinson's disease, Alzheimer's disease, major depressive disorder; and used as an anti-aging drug, achieved its place in research and therapy as the first selective inhibitor of B-type monoamine oxidase (MAO-B)."4.93The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015). ( Miklya, I, 2016)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miklya, I1
Sterling, J1
Herzig, Y1
Goren, T1
Finkelstein, N1
Lerner, D1
Goldenberg, W1
Miskolczi, I1
Molnar, S1
Rantal, F1
Tamas, T1
Toth, G1
Zagyva, A1
Zekany, A1
Finberg, J1
Lavian, G1
Gross, A1
Friedman, R1
Razin, M1
Huang, W1
Krais, B1
Chorev, M1
Youdim, MB1
Weinstock, M1
Smith, RC1
Ho, BT1
Kralik, P1
Vroulis, G1
Gordon, J1
Wolff, J1
Yu, PH1

Reviews

2 reviews available for phenethylamine and Acute Confusional Senile Dementia

ArticleYear
The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015).
    Molecular psychiatry, 2016, Volume: 21, Issue:11

    Topics: Aging; Alzheimer Disease; Animals; Brain; Catecholamines; Depressive Disorder, Major; Dopamine; Hist

2016
Pharmacological and clinical implications of MAO-B inhibitors.
    General pharmacology, 1994, Volume: 25, Issue:8

    Topics: Aging; Alzheimer Disease; Animals; Depressive Disorder; Humans; Mental Disorders; Monoamine Oxidase

1994

Other Studies

2 other studies available for phenethylamine and Acute Confusional Senile Dementia

ArticleYear
Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.
    Journal of medicinal chemistry, 2002, Nov-21, Volume: 45, Issue:24

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Binding Sites; Butyrylcholinesterase; Carbamates;

2002
Platelet monamine oxidase in Alzheimer's disease.
    Journal of gerontology, 1982, Volume: 37, Issue:5

    Topics: Aged; Alzheimer Disease; Blood Platelets; Dementia; Humans; Monoamine Oxidase; Phenethylamines; Subs

1982